HLVX - Hillevax Inc

HLVX - Hillevax Inc

https://www.hillevax.com

Recent News

Powered by Alpha Vantage

HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX - XOMA Royalty ( NASDAQ:XOMA ) , HilleVax ( NASDAQ:HLVX )

Benzinga • 3 weeks, 5 days ago • score: 0.36

NEW YORK CITY and NEW ORLEANS, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ( "KSF" ) are investigating the proposed sale of HilleVax, Inc.

Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session - HilleVax ( NASDAQ:HLVX ) , Kosmos Energy ( NYSE:KOS )

Benzinga • 1 month, 1 week ago • score: 0.42

U.S. stock futures were higher this morning, with the Dow futures gaining more than 200 points on Monday. Shares of Kosmos Energy Ltd. KOS fell sharply in pre-market trading after the company reported worse-than-expected second-quarter results.

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

GlobeNewswire • 1 month, 1 week ago • score: 0.43

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- HilleVax, Inc. ( "HilleVax" or "the Company" ) ( NASDAQ: HLVX ) and XOMA Royalty Corporation ( "XOMA Royalty" ) ( NASDAQ: XOMA ) announced today they have entered into a definitive merger agreement ( the "Merger Agreement" ) , ...

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

GlobeNewswire • 1 month, 1 week ago • score: 0.43

BOSTON, Mass., and EMERYVILLE, Calif., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- HilleVax, Inc. ( "HilleVax" or "the Company" ) ( NASDAQ: HLVX ) and XOMA Royalty Corporation ( "XOMA Royalty" ) ( NASDAQ: XOMA ) announced today they have entered into a definitive merger agreement ( the "Merger ...

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right - XOMA Royalty ( NASDAQ:XOMA ) , HilleVax ( NASDAQ:HLVX )

Benzinga • 1 month, 1 week ago • score: 0.42

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- HilleVax, Inc. ( "HilleVax" or "the Company" ) HLVX and XOMA Royalty Corporation ( "XOMA Royalty" ) XOMA announced today they have entered into a definitive merger agreement ( the "Merger Agreement" ) , whereby XOMA Royalty will ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

HilleVax, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing novel vaccines. The company is headquartered in Boston, Massachusetts.

52W High

$2.17

52W Low

$1.34

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.77

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-4.07

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.71

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

17.09%

Institutions (25–75% balanced)

70.44%

Shares Outstanding

50,126,000

Float

27,408,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-1.44

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.40%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—